About the Agelity® publication
A new peer-reviewed study on Agelity®, Advenion Nutrition’s standardized D-Pinitol ingredient, has been published in the British Journal of Pharmacology. The research explores molecular pathways relevant to brain health and cognitive aging.
The full scientific findings — including the detailed mechanistic data — are available to qualified R&D and formulation partners on request.
By evaluating the specific Agelity® ingredient rather than generic D-Pinitol, the study reinforces the value of standardization and analytical control.
This summary refers to preclinical research intended for scientific and product-development audiences. These statements have not been evaluated by the Food and Drug Administration. Agelity® is an ingredient and is not intended to diagnose, treat, cure, or prevent any disease.